CHRISTINA GRIMM: Open Payments
NPI 1134437130 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 29 payments from 10 companies in 2025. Trend: 2023 $412 · 2024 $498 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 17 | $138 |
| Amgen Inc. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| GENZYME CORPORATION | 1 | $25 |
| Baxter Healthcare | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Pulmonx Corporation | 1 | $16 |
| Electromed, Inc. | 2 | $15 |
| Verona Pharma, Inc. | 1 | $14 |
Products named: NUCALA, TRELEGY ELLIPTA, DUPIXENT, TEZSPIRE, GLASSIA, Hillrom - Monarch Airway Clearance System, FASENRA, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
